Biology subjects

van Spriel, A.

Publications and source records attributed to van Spriel, A..

6 recordsLinked to original sources

bioRxiv2026

Metabolic regulation of cytokine responses in diffuse large B-cell lymphoma

Aberrant communication between cells of the immune system can drive disease progression. Cytokines form the central pilar of immune cell communication and are well established factors in lymphomagenesis. An increasing body of evidence suggests that immunometabolism is tightly connected to cytokine production. However, the exact link between metabolism and cytokine responses during lymphomagenesis remains largely unknown. Here, we used established cell models representing the most common form of B-cell lymphoma, diffuse large B-cell lymphoma (DLBCL), to study the effect of metabolism on cytokine production. We found that stimulation or inhibition of the glycolysis pathway could attenuate IL-6, IL-10 and TNFa; production by DLBCL. Furthermore, we found that two different subtypes of DLBCL displayed distinct metabolic responses to IL-4. In summary, our work suggests that metabolic pathways could be involved in controlling cytokine production in DLBCL, and paves the road for further research aimed at finding specific metabolic targets that can be exploited for therapeutic intervention.

cancer biology↗

bioRxiv2026

TSPAN3 defines a distinct intracellular trafficking route to secretory multivesicular bodies

Extracellular vesicles (EVs) comprise molecularly diverse populations generated through multiple membrane-trafficking pathways, yet the intracellular basis of this heterogeneity remains poorly understood. Here, we identify the EV-associated tetraspanin TSPAN3 as a marker of a secretory multivesicular body (MVB) population that is molecularly and functionally distinct from canonical CD63-positive compartments. Using endogenous genome editing, live-cell and super-resolution microscopy, electron microscopy, quantitative EV secretion assays, and complementary proteomic approaches, we show that TSPAN3 localizes to fusion-competent MVBs but exhibits limited overlap with CD63 during secretion. Unlike CD63, which extensively traffics through the plasma membrane and depends on YXX{Phi}-mediated endocytic retrieval, TSPAN3 reaches secretory MVBs predominantly through an intracellular trafficking route that relies on a dileucine-containing sorting region. Orthogonal proximity-labeling and affinity-purification proteomics revealed that TSPAN3-positive compartments are associated with a selective LC3/ATG8-related membrane network, including GABARAPL2 and proteins involved in endosomal membrane remodeling and fusion. Perturbation of residues required for this association impaired localization to LC3-positive compartments and reduced secretory MVB fusion. Consistent with these findings, pharmacological disruption of autophagy- and endolysosomal-associated pathways differentially altered TSPAN3-positive EV secretion. Finally, proximity-labeled EV proteomics demonstrated that TSPAN3-associated EVs possess cargo signatures distinct from CD63-associated EVs, with greater representation of endosomal and endolysosomal proteins suggesting that tetraspanin-associated membrane nanodomains retain molecular signatures consistent with their intracellular trafficking history. Together, our findings identify TSPAN3 as a marker of a previously unrecognized secretory MVB population distinguished by its intracellular trafficking, molecular interactions, and EV composition, supporting a model in which distinct tetraspanin-organized membrane nanodomains are associated with different intracellular trafficking routes and molecularly distinct EV populations.

cell biology↗

bioRxiv2025

Tetraspanin CD82 reduces the formation of CADM1 oligomers

CD82 is a member of the tetraspanin protein superfamily and known as a metastasis suppressor. We identified cell adhesion molecule 1 (CADM1) as an interaction partner of CD82. CADM1 mediates cell adhesion by forming cis and trans oligomers that connect membranes. We show that CD82 reduces the formation of CADM1 oligomers when solubilized by detergent, on liposomes and in cellulo using Jurkat T-cells. Our data is consistent with a 1:1 complex of CD82 and CADM1 in cis that leaves the CADM1 trans-interaction site accessible. Cryo-electron microscopy of the CD82:CADM1 heterodimer suggests an interaction site between the large-extracellular loop of CD82 and an Ig-like domain of CADM1. Consistently, liposomes coupled with CADM1 ectodomain show reduced clustering when reconstituted with CD82. We hypothesize that CD82 may affect spacing of the transmembrane helices of CADM1, possibly by interacting with the extracellular Ig-like domains and hence disrupting CADM1 oligomerization between membranes.

biochemistry↗

bioRxiv2024

Small molecule inhibitor combination treatment effectively represses global B-cell signaling in diffuse large B-cell lymphoma

Cells sense their environment via signaling networks and malignant cells often hijack signaling pathways for their growth, which complicates defining the effects of drugs. Here, we map the state of the signaling network of B-cell lymphoma cells via simultaneous quantification of 111 (phospho-)proteins. We demonstrate that the B-cell signaling network can be disrupted with specific clinical small molecule inhibitors (iBTK, iSYK, iNF{kappa}B), thereby inducing a repressed state of the network. Principal component analysis identifies how the three inhibitors work along subtly different repression axes through the signaling state landscape. Finally, we observe that 1 {micro}M combination treatment with all three inhibitors is more effective in inducing the repressed state than 10 {micro}M of the single inhibitors. These results emphasize that cellular signaling occurs in complex networks, and underscore how quantification of the signaling state landscape provides insights into how combination drug treatments can bring cells in a desired network state.

molecular biology↗

bioRxiv2023

Galectin-9 regulates dendritic cell contractility and migration via RhoA

Adaptive immunity relies on dendritic cell (DC) migration to transport antigens from tissues to lymph nodes. Galectins, a family of {beta}-galactoside-binding proteins, control cell membrane organisation, exerting crucial roles in multiple physiological processes. Here, we report a novel mechanism underlying cell polarity and uropod retraction. We demonstrate that galectin-9 regulates chemokine-driven and basal DC migration both in humans and mice, indicating a conserved function for this lectin. We identified the underlying mechanism, namely a deficiency in cell rear contractility mediated by galectin-9 interaction with CD44 that in turn regulates RhoA activity. Analysis of DC motility in the 3D tumour-microenvironment revealed galectin-9 is also required for DC infiltration. Moreover, exogenous galectin-9 rescued the motility of tumour-immunocompromised human blood DCs, validating the physiological relevance of galectin-9 in DC migration and underscoring its implications for DC-based immunotherapies. Our results identify galectin-9 as a necessary mechanistic component for DC motility and highlight a novel role for the lectin in regulating cell polarity and contractility.

immunology↗

bioRxiv2023

Glycosylation differentially affects immune cell-specific tetraspanins CD37 and CD53

Tetraspanin proteins play an important role in many cellular processes as they are key organizers of different receptors on the plasma membrane. Most tetraspanins are highly glycosylated at their large extracellular loop, but the function of this post-translational modification remains largely unstudied. In this study we investigated the effects of glycosylation of CD37 and CD53, two tetraspanins important for cellular and humoral immunity. Broad and cell-specific repertoires of N-glycosylated CD37 and CD53 were observed in human B cells. We generated different glycosylation mutants of CD37 and CD53 and analyzed their localization, nanoscale organization and partner protein interaction capacity. Abrogation of glycosylation in CD37 revealed the importance of this modification for CD37 surface expression, whereas neither surface expression nor nanoscale organization of CD53 was affected by its glycosylation. CD37 interaction with its known partner proteins, CD20 and IL-6R, was not affected by glycosylation, other than via its changed subcellular localization. Surprisingly, glycosylation was found to inhibit the interaction between CD53 and its partner proteins CD45 and CD20. Together, our data show that tetraspanin glycosylation affects their function in immune cells, which adds another layer of regulation to tetraspanin-mediated membrane organization.

cell biology↗